The Path To Commercialize CAR-T Cell Products – Science Trends
Science Trends |
The Path To Commercialize CAR–T Cell Products
Science Trends Among such treatments are genetically-engineered CAR T cells that bypass the natural function of patients' T cells to efficiently target and kill tumors. Two CAR T cell products were recently approved by the FDA, and their administration is limited to … |
